• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Glossary

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

M

Marketed Product
For the purposes of disclosure a marketed (also known as approved) product is a medicine that has received regulatory approval in at least one market, for any one indication.
Marketing Authorisation Application (MAA)
See also New Drug Application (NDA)
Ministry of Health, Labour and Welfare Japan (MHLW)
The Pharmaceutical and Food Safety Bureau of the Japanese Ministry of Health, Labour and Welfare (MHLW) implements measures for securing the efficacy and safety of drugs/quasi-drugs, cosmetics and medical devices, safety measures for medical institutions, and measures against narcotics and stimulants.
Multicentre Trial Study
A clinical trial study conducted according to a single study protocol but at more than one site, and therefore, carried out by more than one investigator.

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013